Revealing DNA-Encoded Incretin Mimetics for Sustained Therapeutic Effects
- Investigating a novel DNA-based platform for sustained in vivo GLP-1 production following a single administration
- Examining DNA electroporation for delivery of brain-targeted incretin mimetics for precise hunger modulation
- Assessing strategies for half-life extension of incretin to reduce dosing frequencies for improved patient adherence